Taiguang Jin
Head of Discovery Biology
BrightPath Biotherapeutics
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Taiguang Jin is the Head of Discovery Biology at Bridge Biotherapeutics, Inc. in the United States. His research primarily focuses on targeted therapies for cancer treatment, with recent investigations into fourth-generation tyrosine kinase inhibitors for osimertinib-resistant EGFR mutations in non-small cell lung cancer. Dr. Jin's work aims to advance effective treatment options for challenging cancer mutations.
Articles (1)
Year:
2023
Collaborators (2)
Gwanghee Lee
-
SOUTH KOREA
Dong-Wan Kim
Associate Professor
Seoul National University Hospital
SOUTH KOREA
Make your next move.
Prepare your application
Review drafts before you send them.